May 12, 2025
Artificial Intelligence (AI) has already been used in many areas of clinical development and clinical...
Apr 22, 2025
Eyal Wultz, Bioforum Co-founder and BionData Co-founder and President Data integrity in clinical trials refers...
Apr 14, 2025
Authored by Eyal Wultz, Bioforum Co-founder and BionData Co-founder and President Over the past few...
Apr 06, 2025
Small biotech companies encounter significant challenges in designing and implementing clinical development programmes. These companies...
Mar 24, 2025
Accelerating Innovation in Structural Heart Care: Bioforum’s Role in Pi-Cardia’s FDA Journey Bioforum is proud...
Feb 17, 2025
Sample size is a quantity of immense strategic and ethical importance in treatment development. It...
Feb 11, 2025
As medical writers, staying ahead of regulatory changes is crucial. The Transition from ICH E6...
Jan 16, 2025
Introduction With over 50%[1] of drugs in development reflecting rare/orphan and oncology indications alone, the...
Jan 12, 2025
Drug development is a high-stakes, high-cost endeavor. Every new drug entering clinical trials requires careful...
Dec 10, 2024
Value of strategic statistical consultants Many sponsors are restricting the utilization of strategic statistical consultants...
May 19, 2024
Data standards support the robust organization, analysis, and reporting of clinical trials and many regulatory...
Apr 19, 2024
If you’re contemplating a Functional Service Provision (FSP) model to enhance your biometric team, understanding...